Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Shak Insider Profile
4 Followers
Steven Shak, CSO at Genomic Health, holds 0.00 shares in Genomic Health (Ticker: GHDX).
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-5.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Steven Shak does not currently own shares as a corporate insider.
A breakdown of Steven Shak's holdings
Insider Roles
Steven Shak does not currently hold a role as a corporate insider.
Roles that Steven Shak holds in companies
Most Profitable Insider Trade
Stock:
Genomic Health
(GHDX)
(GHDX)
Rating:Informative Sell
Date:Mar 05, 2019 - Mar 05, 2020
Return:0.00%
The most profitable trade made by Steven Shak
Steven Shak's Trading History
List of latest transactions for each holding click on a transaction to see Steven Shak's performance on stock
You May Also Like
Steven Shak insider profile FAQ
What is the percentage of profitable transactions made by Steven Shak?
The percentage of profitable transactions made by Steven Shak is 0%.
What is the average return per transaction made by Steven Shak?
The average return per transaction made by Steven Shak is -5.40%.
What stocks does Steven Shak hold?
Steven Shak holds: GHDX stocks.
What was Steven Shak’s latest transaction?
Steven Shak latest transaction was an Uninformative Sell of ―.
What was Steven Shak's most profitable transaction?
Steven Shak’s most profitable transaction was an Informative Sell of GHDX stock on March 5, 2019. The return on the trade was 0.00%.
What is Steven Shak's role in Genomic Health?
Steven Shak's role in Genomic Health is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.